Shares of Starpharma Holdings Ltd. (OTCMKTS:SPHRY – Get Free Report) traded down 7.1% on Friday. The stock traded as low as $3.02 and last traded at $3.25. Approximately 1,100 shares traded hands during trading, an increase of 43% from the average daily volume of 768 shares. The stock had previously closed at $3.50.
Starpharma Stock Down 7.1%
The firm’s 50 day moving average price is $5.08 and its two-hundred day moving average price is $4.37.
Starpharma Company Profile
Starpharma is an Australian biotechnology company focused on developing pharmaceutical products and medical applications based on its proprietary dendrimer technology. Dendrimers are highly branched, nanoscale polymers that can be engineered to deliver active ingredients or provide antiviral and antimicrobial effects.
The company’s best-known product is VivaGel BV, a vaginal gel containing astodrimer sodium that is designed to treat and help prevent the recurrence of bacterial vaginosis.
Featured Stories
- Five stocks we like better than Starpharma
- Amazon’s Record Margins Couldn’t Stop the Sell-Off—Here’s Why
- DoorDash’s $17 Billion Bet on Instacart Faces a Long Regulatory Road Ahead
- FTC Puts A Wrinkle In the Cintas and UniFirst Merger
- Breaching the Valuation: The Real Reason Fortinet Dropped
Receive News & Ratings for Starpharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Starpharma and related companies with MarketBeat.com's FREE daily email newsletter.
